Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FWGBH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,763
Award facts
- Contract value 100% obligated
- $29,763.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $29,763.27 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pens on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price contract does not include a set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables supply of a comprehensive range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill diverse pharmaceutical procurement requirements through open competition, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The delivery order for Dupixent supports the Defense Health Agency and other government healthcare systems through the flexible SPE2DX contract vehicle, which is part of DLA's broader strategy to establish regional pharmaceutical prime vendor contracts with multiple award recipients.
Quick answers
Who was awarded contract SPE2DB26FWGBH?
SPE2DB26FWGBH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FWGBH worth?
The government has obligated $29,763 on SPE2DB26FWGBH.
Is contract SPE2DB26FWGBH an order under another contract?
Yes. SPE2DB26FWGBH is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB26FWGBH competed?
The extent of competition for SPE2DB26FWGBH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award